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INTRODUCTION
Morganella morganii is a facultative gram-negative and anaer-
obic rod found in the feces and intestines of humans, dogs, and
other mammals. It is known to be a causative organism of
opportunistic infections in the respiratory tract, the urinary
tract, and in wound infections. It can cause devastating infec-
tions in the neonates and postoperative stages, especially in
diabetic patients (1). The risk of infection is particulary high
when a patient becomes neutropenic as a result of myelosup-
pressive chemotherapy (2). Massive hemolysis can be associ-
ated with bacterial infection and has been reported mainly in
cases of Clostridial or Vibrio sepsis (3, 4). We report here on a
case of M. morganii sepsis associated with massive hemolysis
in a neutropenic patient who underwent chemotherapy.
CASE REPORT
A 59-yr-old-male was admitted to the emergency room (ER)
with a 1-day history of jaundice, drowsiness, and a high fever.
He had been diagnosed with stage IIIa non-small-cell lung
cancer one year earlier. He had undergone a left pneumonecto-
my followed by 3 courses of adjuvant chemotherapy with ge-
mcitabine and cisplatin. Since the chest computed tomogra-
phy (CT) scan taken after 3 courses of chemotherapy revealed
newly developed mediastinal lymph nodes enlargement, the
chemotherapeutic regimen was switched to paclitaxel and car-
boplatin. He had completed the course of chemotherapy with
paclitaxel and carboplatin 10 days before his admission to the
ER. Two days prior to admission to the ER, he visited the out-
patient department to check the possibility of chemotherapy
induced cytopenias. At that time the patient was afebrile, and
his blood test showed hemoglobin 11.7 g/dL, hematocrit 34
%, a white blood cell count of 2.12×103/ L (8.4% segment-
ed neutrophils, 81.6% lymphocytes, 5.7% monocytes, 3.8%
eosionphils, and 0.5% basophils), and a platelet count of 107
×103/ L. Granulecyte colony-stimulating factor was admin-
istered for the chemotherapy-induced neutropenia. Later that
night he experienced fever and chills. The day before his admis-
sion, jaundice and dark red-colored urine developed. On admis-
sion, he was icteric and lethargic. He was drowsy but there were
no focal neurological findings. There was no history of drug
overuse. His blood pressure was 180/100 mmHg, the heart
rate was 135 beats/min, the respiration rate was 24 breaths/min,
and his temperature was 36℃. His arterial acid/base status
was as follows: pH 7.04, pCO2 14 mmHg, pO2 77 mmHg,
HCO3- 3.8 mM/L, SaO2 87%. The laboratory findings were
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Morganella Morganii Sepsis with Massive Hemolysis
Morganella morganii is a facultative gram-negative and anaerobic rod. It may be a
cause of devastating infections in neonates and immunocompromised hosts. Some
bacterial infections such as Clostridium and Vibrio are associated with hemolysis.
However, massive hemolysis caused by M. morganii sepsis has not yet been report-
ed. We observed a 59-yr-old man who had chemotherapy-induced neutropenia
and was found to have massive hemolysis and metabolic acidosis due to sepsis.
He died 6 hr after admission in spite of aggressive treatment. Two sets of blood
cultures revealed the growth of M. morganii. We report here that M. morganii sep-
sis can cause fatal massive hemolysis leading to death.
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as follows: hemoglobin 4.8 g/dL, hematocrit 6.9%, white blood
cell count 2.47×103/ L (11.8% segmented neutrophils, 77.7
% lymphoctes, 8.5% monocytes, 0.8% eosinophils, 1.2% ba-
sophils), platelets 71×103/ L, reticulocyte count 60.7%, total
bilirubin 31 mg/dL, direct bilirubin 5.6 mg/dL, aspartate trans-
ferase 9 IU/L, alanine transferase 7 IU/L, blood urea nitrogun
47 mg/dL, and creatinine 1.0 mg/dL. Electrolytes, ionized
calcium, and glucose levels were all within normal limits. A
peripheral blood smear showed polychromatric and sphero-
cytic red blood cells, toxic vacuolation and toxic granulated
neutrophils. Direct and indirect antiglobulin tests were all
negative. The level of glucose- 6-phosphate dehydrogenase was
within the normal range. Chest radiography and electrocar-
diogram findings did not show any abnormalities. A CT scan
of the abdomen revealed a 3 cm-sized focal parencymal de-
structive lesion with air in S6 of the liver, mild dilated intra-
hepatic duct without stones, and periductal edema, indicat-
ing a gas-forming abscess in liver. The patient had a history
of a left lobectomy of the liver due to a villotubular adenoma
and intrahepatic duct stones. His condition deteriorated rapid-
ly in spite of intensive treatment. After sampling blood and
urine for microbiological examination, antibiotics composed
of ceftazidime 2 gm and amikacin 500 mg were injected intra-
venously on the basis of suspected neutropenic sepsis. Despite
the adequate replacement of sodium bicarbonate and oxygen,
severe metabolic acidosis and hypoxemia were not corrected.
Cardiac arrest followed, and he died 6 hr after admission. An
autopsy was not performed according to the familys decision.
Two sets of blood cultures were incubated (VITAL, bioMerieux,
Marcy-L Etoile, France), and both showed the growth of M.
morganii. Antibiotic susceptibility testing was performed using
VITEK 2 (bioMerieux, Marcy-L Etoile). While the isolate was
resistant to ampicillin, cephalothin, and trimethoprim/sul-
famethoxazole, it was sensitive to cefotaxime, ceftazidime, aztre-
onam, gentamicin, amikacin, ciprofloxacin, and imipenem.
DISCUSSION
The case presented here is unique and interesting since M.
morganii seldom causes sepsis and massive hemolysis associated
with this organism in human being has not been previously
reported. This patient was in a condition of severe neutope-
nia that made him susceptible to bacteremia. When cytotoxic
chemotherapy is used to treat cancer, it has potent effects on
both humoral and cellular immunity. All types of infections
are associated with higher rates of morbidity and mortality
in patients who receive chemotherapy (5). Within the enter-
obacteriaceae, the genus M. morganii belongs to the tribe Pro-
teeae, which also includes the genera Proteus and Providen-
cia. It resides in human colonic mucosa as a normal flora. It
is well known that it may cause an opportunistic infection,
especially in an immunocompromised host. The majority of
M. morganii infections are related to postoperative wound in-
fection and urinary tract infection. Mylotte et al. reported that
the risk factors for M. morganii infection were old age, the pres-
ence of a serious underlying disease, the presence of concomi-
tant bacteremia, hospitalization, recent surgery, and concur-
rent antibiotic use. M. morganii infections do not typically in-
duce bacteremia. However, bacteremia caused by M. morganii
infection can be associated with a mortality rate of 22-38%.
According to a review recently published, M. morganii sepsis
frequently occurred secondary to urinary tract or hepatobil-
iary tract infection. It was associated with a high mortality rate,
especially for patients with solid tumors, diabetes, polymicro-
bial bacteremia, and inappropriate antibiotic treatment. The
major portals of entry of M. morganii bacteremia were the uri-
nary tract, followed by the hepatobiliary tract (6-8). Massive
hemolysis, a rare but well-known and characteristic compli-
cation of Clostridium perfringens, has been reported in cases of
postabortion and postpartum infections and gas gangrene (9).
In C. perfringens infection, alpha-toxin gives rise to lysis of the
erythrocytes. Intravascular hemolysis is caused by the alpha
toxin, which is a phospholipase C lecithinase. The alpha toxin
hydrolyzes sphingomyelin and lecithine to phosphoryl choline
and diglyceride and, therefore, can cause the lysis of red blood
cells, white blood cells, platelets, and endothelial cells. There
are reports that Bacillus cereus, Vibrio vulnificus, and Haemophilus
influenzae can also cause intravascular hemolysis (10). Recent
studies showed that 56% of M. morganii strains could produce
the hemolysin and that there is a genetic homology between
the hemolysin of M. morganii and the alpha hemolysin of Esc-
herichia coli. It has been reported that the M. morganii hemolysin
causes hemolysis by generating a pore in the erythrocyte mem-
brane. M. morganii hemolysin might also cause leakage of
ATP in human granulocytes, leading to cell death. Production
of this hemolysin seems to be lethally virulent. Intranasal ap-
plication of the hemolytic strains in mice caused death with-
in a short time and hemorrhagic lung edema was found dur-
ing an autopsy (11).
Chemotherapy-induced side effects can be thought of as
the cause of hemolytic anemia and metabolic acidosis in this
case. However, it has not been reported that chemotherapeu-
tic agents such as paclitaxel and carboplatin, which were ad-
ministered to this patient, cause either massive hemolysis or
metabolic acidosis. Hemolytic uremic syndrome (HUS) should
be ruled out as a possible cause of the massive hemolysis in this
case. In HUS, the expected time frame of the clinical course
is days to weeks and the urinary function is abnormal. This
patient showed a rapid deterioration in the clinical course along
with massive hemolysis and normal renal function. Throm-
botic thrombocytopenic purpura (TTP) can also be a cause of
hemolytic anemia. However, neither HUS nor TTP has been
associated with these drugs. Based on these findings, we diag-
nosed this patient as having sepsis with massive hemolysis due
to M. morganii. The clinical course of hemolysis provoked by
M. morganii infection is not well known. As far as we know,
this is the first case of M. morganiisepsis with massive hemolysis.
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